Mary Shoemaker
Direktor/Vorstandsmitglied bei TRAWS PHARMA, INC.
Vermögen: 2 141 $ am 30.04.2024
Aktive Positionen von Mary Shoemaker
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TRAWS PHARMA, INC. | Direktor/Vorstandsmitglied | 01.04.2020 | - |
| Independent Dir/Board Member | 01.04.2020 | - |
Karriereverlauf von Mary Shoemaker
Ehemalige bekannte Positionen von Mary Shoemaker
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Corporate Officer/Principal | - | 22.05.2020 |
Medexus Pharma, Inc.
 Medexus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Medexus Pharma, Inc. develops treatments for autoimmune diseases. It focuses on development and commercialization of treatments for autoimmune diseases as well as cancer. The company was founded in 2012 and is headquartered in Chicago, IL. | Direktor/Vorstandsmitglied | 01.10.2018 | 01.05.2020 |
| Vorstandsvorsitzender | 01.01.2012 | 01.05.2020 | |
| Präsident | 01.10.2018 | 01.05.2020 | |
| INTERMUNE INC | Vertrieb & Marketing | 06.11.2009 | 01.07.2010 |
Pharmion Corp.
 Pharmion Corp. Pharmaceuticals: MajorHealth Technology Pharmion Corp. engages in the development and commercialization of products for the treatment of hematology and oncology patients. It has operations in Switzerland, Israel, and Philippines. The company was founded by Patrick J. Mahaffy in 1999 and is headquartered in Boulder, CO. | Corporate Officer/Principal | - | - |
Ausbildung von Mary Shoemaker
| University of Central Missouri | Graduate Degree |
| Missouri State University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Kanada | 2 |
Operativ
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Sales & Marketing | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| TRAWS PHARMA, INC. | Health Technology |
| MEDEXUS PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Pharmion Corp.
Pharmion Corp. Pharmaceuticals: MajorHealth Technology Pharmion Corp. engages in the development and commercialization of products for the treatment of hematology and oncology patients. It has operations in Switzerland, Israel, and Philippines. The company was founded by Patrick J. Mahaffy in 1999 and is headquartered in Boulder, CO. | Health Technology |
Medexus Pharma, Inc.
Medexus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Medexus Pharma, Inc. develops treatments for autoimmune diseases. It focuses on development and commercialization of treatments for autoimmune diseases as well as cancer. The company was founded in 2012 and is headquartered in Chicago, IL. | Health Technology |
- Börse
- Insiders
- Mary Shoemaker
- Erfahrung
